FFCD - PRODIGE 86 (FFCD 2103 – GONO – ENGIC 02) – FOLFIRINOX SBA: Phase II randomized trial to evaluate mFOLFIRINOX and mFOLFOX for locally advanced or metastatic small bowel adenocarcinoma

PRODIGE 86 (FFCD 2103 – GONO – ENGIC 02) – FOLFIRINOX SBA: Phase II randomized trial to evaluate mFOLFIRINOX and mFOLFOX for locally advanced or metastatic small bowel adenocarcinoma

Auteurs

Thomas Aparicio, Anthony Turpin, Aziz Zaanan, Christelle de la Fouchardière, Karine Le Malicot, Sara Lonardi, Dominik Paul Modest, Richard Wilson, Alexej Ballhausen, Janet Graham, Meriem Guarssifi, Magali Svrcek, Pierre Laurent Puig, Sylvain Manfredi

Journal / Conférence

ESMO

Type de publication

Poster

Etude

PRODIGE 86 FOLFIRINOX-SBA

Localisation

Intestin grêle